or
forgot password
  • cancer clinical trials in missoula, MT

  • S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

    Trial Locations
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    Montana Cancer Specialists at Montana Cancer Center
    Guardian Oncology and Center for Wellness
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Community Medical Hospital

    Trial Locations
    Community Medical Hospital
    Saint Patrick Hospital - Community Hospital
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Montana Cancer Specialists at Montana Cancer Center
    Missoula, Montana 59802
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

    Trial Locations
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    Montana Cancer Specialists at Montana Cancer Center
    Lung Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Guardian Oncology and Center for Wellness

    Trial Locations
    Guardian Oncology and Center for Wellness
    Montana Cancer Specialists
    Saint Patrick Hospital - Community Hospital
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Montana Cancer Specialists

    Trial Locations
    Montana Cancer Specialists
    Community Medical Hospital
    Saint Patrick Hospital - Community Hospital
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Saint Patrick Hospital - Community Hospital
    Missoula, Montana 59802
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

    Trial Locations
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    Montana Cancer Specialists at Montana Cancer Center
    Leukemia
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

    Trial Locations
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    Montana Cancer Specialists at Montana Cancer Center
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

    Trial Locations
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    Montana Cancer Specialists at Montana Cancer Center
    Liver Cancer
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

    Trial Locations
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    Montana Cancer Specialists at Montana Cancer Center
    Brain and Central Nervous System Tumors
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

    Trial Locations
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    Montana Cancer Specialists at Montana Cancer Center
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

    Trial Locations
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    Montana Cancer Specialists at Montana Cancer Center
    Multiple Myeloma, Plasma Cell Myeloma, Precancerous Condition
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

    Trial Locations
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    Montana Cancer Specialists at Montana Cancer Center
    Community Medical Center
    Guardian Oncology and Center for Wellness
    Lung Cancer
    Dinaciclib in Treating Patients With Stage IV Melanoma
    Guardian Oncology and Center for Wellness

    Trial Locations
    Guardian Oncology and Center for Wellness
    Montana Cancer Specialists
    Community Medical Hospital
    Saint Patrick Hospital - Community Hospital
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Mucosal Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Saint Patrick Hospital - Community Hospital
    Missoula, Montana 59802
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

    Trial Locations
    Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
    Montana Cancer Specialists at Montana Cancer Center
    Leukemia
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Guardian Oncology and Center for Wellness

    Trial Locations
    Guardian Oncology and Center for Wellness
    Montana Cancer Specialists
    Community Medical Hospital
    Saint Patrick Hospital - Community Hospital
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
    Montana Cancer Specialists

    Trial Locations
    Montana Cancer Specialists
    Saint Patrick Hospital - Community Hospital
    Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma